NCT07131059 2025-08-20
MRD-positive AML Clinical Study
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Recruiting
Clinical Trials
12 trialsNCT06697327 2025-05-14
Daunorubicin + Cytarabine + Venetoclax in de Novo AML
Anhui Medical University
Phase NA Enrolling by invitation
NCT05832320 2024-05-10
Optimum Induction Therapy of Low-risk APL
Peking University People's Hospital
Phase NA Recruiting
NCT01156883 2021-09-13
LAL1308
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase NA Completed
NCT01953770 2020-02-05
ALL-MB 2008
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase NA Unknown
NCT00550992 2019-07-30
Interfant06
Dutch Childhood Oncology Group
Phase NA Unknown
NCT00096135 2017-03-21
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
Children's Oncology Group
Phase NA Completed
NCT02432872 2016-10-07
Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 Years
ChineseAMS
Phase NA Unknown
NCT01225874 2016-02-23
Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL
Children's Oncology Group
Phase NA Completed
NCT00187057 2015-08-27
Study for Treatment of Cancer in Children With Ataxia-telangiectasia
St. Jude Children's Research Hospital
Phase NA Completed
NCT00343369 2013-08-26
Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Phase NA Unknown
NCT00537550 2007-10-01
LAL2000
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase NA Completed